Prevalence of Dissociative Disorders in Children
This study is currently recruiting participants.
Verified January 2012 by Centre Hospitalier Universitaire de Nice
Sponsor:
Centre Hospitalier Universitaire de Nice
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT01512641
First received: December 13, 2011
Last updated: August 6, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Schizophrenia beginning before 18 years is a clinical entity not well known because of its low incidence and difficulties in the clinical diagnosis.
However, in the investigators clinical practice, due to the specialization of the investigators service, the investigators are led to hospital to receive important feel active of patients meeting the Diagnostic and Statistical Manual of Mental Disorders IV text revision (DSM IV-TR) precose schizophrenia.
The work of us team on the theme of the relationship between Pervasive Developmental Disorders and precose Schizophrenia led us to hypothesize that a number of children in care in the medical and educational institutes, hospitals and day shelters therapeutic part-time symptoms of schizophrenia or a line real early diagnosis of schizophrenia undervalued or not diagnosed.
The main goal is to estimate the prevalence of dissociative disorders in a population of children in care institutions and medical education in child psychiatry in hospitals and others structures.
| Condition | Intervention |
|---|---|
|
Dissociative Disorders Schizophrenia |
Other: Primary stage Other: Secondary stage |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Prevalence of Dissociative Disorders in Children in a Population Supported in the Medico-social and Health Structures in Provence Alpes Cote d'Azur |
Resource links provided by NLM:
Further study details as provided by Centre Hospitalier Universitaire de Nice:
Primary Outcome Measures:
- Rate of children diagnosed with dissociative disorders [ Time Frame: between 2 and 4 hours depending children ] [ Designated as safety issue: No ]Rate of children diagnosed with dissociative disorders: children positive for the test Kiddie-Schedule for Affective Disorders and Schizophrenia (Kiddie-SADS).
Secondary Outcome Measures:
- Percentage of children positive for test: Autism Diagnostic Interview-Revise (ADI-R). [ Time Frame: 1 day on average ] [ Designated as safety issue: No ]
- Scores of three dimensions of schizophrenia in the Positive And Negative Syndrome Scale (PANSS) [ Time Frame: 4 hours ] [ Designated as safety issue: No ]3 dimensions: positive symptoms, negative symptoms and general psychopathology, based on these scores the diagnostic subtype of schizophrenia is established.
- Score at the Test Lillois de Communication (TLC) [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
- Score on the Wechsler Intelligence Scale for Children-Fourth Edition (WISC IV)subtests and overall intelligence quotient (IQ). [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
- Response time to test verbal fluency, scores on the Trail Making Test A (TMT) and TMT B. [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 3360 |
| Study Start Date: | December 2011 |
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Children with Dissociative Disorders
Children will take first the primary stage. If one child is positive, he will pass the secondary stage.
|
Other: Primary stage
Kiddie-Schedule for Affective Disorders and Schizophrenia
Other: Secondary stage
children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV
|
Eligibility| Ages Eligible for Study: | 7 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 7 to 18 years
- Supported in the partner institutions of the study
- IQ>35 on the certificate of orientation of the Maison Départementale des Personnes Handicapées (MDPH)
- Obtaining the agreement of parents and children
Exclusion Criteria:
- QI<35 on the certificate file Guidance MDPH
- Children not speaking french
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01512641
Contacts
| Contact: Florence ASKENAZY, PU-PH | 04 92 03 03 72 ext +33 | florence.askenazy@lenval.com |
| Contact: Emmanuelle DOR, PH | 04 92 03 03 72 | dor.nedonsel@lenval.com |
Locations
| France | |
| Psychiatrie infanto-juvénile - Centre Hospitalier d'Antibes | Recruiting |
| Antibes, France, 06600 | |
| Contact: Michel BOUBLIL, Docteur en médecine 04 92 91 79 50 ext +33 michel.boublil@ch-antibes.fr | |
| Principal Investigator: Michel BOUBLIL, PH | |
| Psychiatrie infanto-juvénile-Pôle femme-mère -enfant | Not yet recruiting |
| Fréjus, France, 83608 | |
| Contact: Michèle BATTISTA, DOCTEUR EN MEDECINE 04 94 40 21 48 ext +33 battista-m@chi-frejus-saint-raphael.fr | |
| Service de psychiatrie de l'enfant et de l'adolescent | Not yet recruiting |
| Marseille, France, 13009 | |
| Contact: François POINSO, PU-PH 04 91 74 58 44 ext +33 | |
| Principal Investigator: François POINSO, PU PH | |
| Sub-Investigator: Xavier SALLE-COLLEMICHE, PH | |
| Service de psychiatrie de l'enfant et de l'adolescent | Recruiting |
| Nice, France, 06000 | |
| Contact: Emmanuelle DOR, PH 04 92 03 03 72 ext +33 dor.nedonsel@lenval.com | |
| Contact: Cassandre LANDES, Ingenieur 04 92 03 45 88 ext +33 landes.c@chu-nice.fr | |
| Principal Investigator: Florence ASKENAZY, PU-PH | |
| Principal Investigator: Emmanuelle DOR, PH | |
| Sub-Investigator: Anne Lise TOSELLO, psychologue | |
| Sub-Investigator: Fanny MARIA, Psychologue | |
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Investigators
| Study Director: | Florence ASKENAZY, PU-PH | University hospital of Nice |
| Principal Investigator: | Emmanuelle DOR, PH | University hospital of Nice |
| Principal Investigator: | François POINSO, PU-PH | AP-HM |
| Principal Investigator: | Michèle BATTISTA, PH | Frejus's hospital |
| Principal Investigator: | Michel BOUBLIL, PH | Antibes's hospital |
More Information
No publications provided
| Responsible Party: | Centre Hospitalier Universitaire de Nice |
| ClinicalTrials.gov Identifier: | NCT01512641 History of Changes |
| Other Study ID Numbers: | 11-API-01 |
| Study First Received: | December 13, 2011 |
| Last Updated: | August 6, 2012 |
| Health Authority: | France: Committee for the Protection of Personnes France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Centre Hospitalier Universitaire de Nice:
|
children dissociative disorders schizophrenia |
Additional relevant MeSH terms:
|
Dissociative Disorders Conversion Disorder Schizophrenia |
Mental Disorders Somatoform Disorders Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on May 22, 2013